B. Metzler seel. Sohn & Co. AG trimmed its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 43.8% in the second quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 10,563 shares of the company's stock after selling 8,217 shares during the quarter. B. Metzler seel. Sohn & Co. AG's holdings in HCA Healthcare were worth $4,118,000 as of its most recent filing with the SEC.
Other large investors also recently made changes to their positions in the company. Palisade Asset Management LLC bought a new position in shares of HCA Healthcare in the third quarter valued at $26,000. Cedar Mountain Advisors LLC acquired a new stake in HCA Healthcare in the first quarter valued at $33,000. MCF Advisors LLC increased its stake in shares of HCA Healthcare by 213.0% during the 4th quarter. MCF Advisors LLC now owns 72 shares of the company's stock worth $34,000 after purchasing an additional 49 shares during the last quarter. MidFirst Bank acquired a new stake in HCA Healthcare in the 2nd quarter valued at about $28,000. Finally, Clearstead Trust LLC acquired a new position in HCA Healthcare during the second quarter worth approximately $29,000. Institutional investors own 62.73% of the company's stock.
Analysts Set New Price Targets
Several brokerages have recently commented on HCA. Weiss Ratings downgraded HCA Healthcare from a "buy (b-)" rating to a "hold (c+)" rating in a research note on Tuesday, June 9th. Jefferies Financial Group set a $450.00 price objective on shares of HCA Healthcare in a research report on Tuesday, July 14th. Oppenheimer dropped their price objective on shares of HCA Healthcare from $520.00 to $485.00 and set an "outperform" rating on the stock in a research report on Monday, July 27th. Barclays decreased their price target on shares of HCA Healthcare from $402.00 to $387.00 and set an "equal weight" rating on the stock in a research note on Monday, July 27th. Finally, Robert W. Baird cut their price objective on shares of HCA Healthcare from $396.00 to $393.00 and set a "neutral" rating for the company in a research report on Monday, July 27th. Fourteen equities research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the company's stock. Based on data from MarketBeat.com, HCA Healthcare has an average rating of "Moderate Buy" and an average target price of $462.64.
Read Our Latest Stock Analysis on HCA Healthcare
HCA Healthcare Trading Down 1.0%
NYSE HCA opened at $404.95 on Friday. The company has a fifty day simple moving average of $403.35 and a 200 day simple moving average of $437.55. HCA Healthcare, Inc. has a 12-month low of $353.99 and a 12-month high of $556.52. The company has a market cap of $87.67 billion, a P/E ratio of 13.56, a PEG ratio of 1.35 and a beta of 1.10.
HCA Healthcare (NYSE:HCA - Get Free Report) last issued its quarterly earnings data on Friday, July 24th. The company reported $7.59 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $7.56 by $0.03. The firm had revenue of $20.23 billion during the quarter, compared to analysts' expectations of $19.76 billion. HCA Healthcare had a net margin of 8.77% and a negative return on equity of 244.79%. The business's revenue was up 8.7% on a year-over-year basis. During the same period last year, the company earned $6.84 earnings per share. Sell-side analysts predict that HCA Healthcare, Inc. will post 29.42 EPS for the current year.
HCA Healthcare Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Wednesday, September 30th. Stockholders of record on Wednesday, September 16th will be paid a dividend of $0.78 per share. The ex-dividend date is Wednesday, September 16th. This represents a $3.12 annualized dividend and a dividend yield of 0.8%. HCA Healthcare's dividend payout ratio (DPR) is presently 10.45%.
About HCA Healthcare
(
Free Report)
HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.
The company's core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA's services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider HCA Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HCA Healthcare wasn't on the list.
While HCA Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
